Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence of Minocycline ER 135 mg vs Solodyn in Healthy Males
NCT02312297Phase 1Completed
- Sponsor
- Ranbaxy Laboratories
- Start
- Sep 2008
- Primary completion
- Sep 2008
- Modality
- Small Molecules
01
Overview
Phase 1, randomised, open-label trial of minocycline in acne vulgaris (2 arms), sponsored by Ranbaxy Laboratories. Primary endpoints: Area Under the Curve and Peak Plasma Concentration. Started Sep 2008; status: completed.
02
Drugs
minocycline
03
Conditions
acne vulgaris
Beyond the preview
Go deeper on NCT02312297.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02312297.